# Trade Mark Journal No.2025/031 1 August 2025

## WO0000001864690 (5)

Office of origin: Australia

Date of International Registration:6 May 2025
Date of designation in the UK: 6 May 2025

International priority date claimed: 20 November 2024 (Australia) (2500412)

Class 5
  Pharmaceutical preparations for use in the treatment of cancer, autoimmune disease, and immune system-related diseases and disorders; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising covalently binding proteins; immunotherapeutic drugs; engineered T cell receptors, for medical purposes; covalently binding proteins, for medical purposes; reagents for medical use; diagnostic reagents for medical use; diagnostic preparations for medical purposes.

Resseptor Therapeutics Pty Ltd

Representative: Resseptor Therapeutics, Jumar Bioincubator,, 655 Elizabeth St, Melbourne VIC 3000, AUSTRALIA